Sarah Kiguli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sarah Kiguli has a total of 312 co-authors. Here are the top co-authors by number of shared publications:
- Peter Olupot-Olupot
Department of Public Health, Faculty of Health Sciences, Busitema University, Mbale, Uganda
10 shared publications - David Mukunya
Department of Community and Public Health, Busitema University Faculty of Health Sciences, Mbale, Uganda
7 shared publications - Ian Munabi
College of Health Sciences, School of Medicine, Makerere University, Kampala, Uganda
7 shared publications - Charles Engoru
Department of Paediatrics, Soroti Regional Referral Hospital, Soroti, Uganda
5 shared publications - Charles Karamagi
Department of Paediatrics and Child Health, College of Health Sciences, Makerere University, Kampala, Uganda
5 shared publications - Diana M. Gibb
Medical Research Council Clinical Trials Unit at University College London, London, United Kingdom
5 shared publications
Latest Publications
- Open Access
- 24 October 2026
- Published by Springer Nature in BMC Infectious Diseases
The resurgence of blackwater fever among children in sub-Saharan Africa: a scoping review
- 24 October 2026
- Published by Springer Nature in BMC Infectious Diseases
Open AccessThe resurgence of blackwater fever among children in sub-Saharan Africa: a scoping review
- Open Access
- 12 October 2026
- Published by Springer Nature in BMC Global and Public Health
- Vol. 4 (1) , 99
A national spatial prioritisation framework for the targeted expansion of essential sickle cell disease services across health-facility catchments in Uganda
- 12 October 2026
- Published by Springer Nature in BMC Global and Public Health
- Vol. 4 (1) , 99
Open AccessA national spatial prioritisation framework for the targeted expansion of essential sickle cell disease services across health-facility catchments in Uganda
- Open Access
- 25 September 2026
- Published by Springer Nature in BMC Medical Education
Evaluating the hospital learning environment for medical interns in Uganda: a cross-sectional study at three national referral hospitals
- 25 September 2026
- Published by Springer Nature in BMC Medical Education
Open AccessEvaluating the hospital learning environment for medical interns in Uganda: a cross-sectional study at three national referral hospitals
- Open Access
- 4 March 2026
- Published by Taylor & Francis in Hemoglobin
- Vol. 50 (2) , 111-120
SickleInAfrica Consortium: A Seven-Country Study Evaluating the Performance of Dried Blood Spot Point-of-Care Testing in Newborn Screening for Sickle Cell Disease
Sickle cell disease (SCD) is caused by an inherited single-nucleotide substitution in both copies of the β-globin gene [HBB(Glu7Val)]. The sickle-cell mutation results in the production of an abnor...
- 4 March 2026
- Published by Taylor & Francis in Hemoglobin
- Vol. 50 (2) , 111-120
Open AccessSickleInAfrica Consortium: A Seven-Country Study Evaluating the Performance of Dried Blood Spot Point-of-Care Testing in Newborn Screening for Sickle Cell Disease
Sickle cell disease (SCD) is caused by an inherited single-nucleotide substitution in both copies of the β-globin gene [HBB(Glu7Val)]. The sickle-cell mutation results in the production of an abnor...
- Open Access
- 3 March 2026
- Published by Springer Nature in Malaria Journal
- Vol. 25 (1)
A maximal-coverage approach to prioritizing newborn sickle cell screening sites in Uganda using a sickle cell-malaria co-risk surface
Uganda has a high, spatially heterogeneous burden of sickle cell disease (SCD) with national screening indicating sickle cell trait at 13.1 percent and dis
- 3 March 2026
- Published by Springer Nature in Malaria Journal
- Vol. 25 (1)
Open AccessA maximal-coverage approach to prioritizing newborn sickle cell screening sites in Uganda using a sickle cell-malaria co-risk surface
Uganda has a high, spatially heterogeneous burden of sickle cell disease (SCD) with national screening indicating sickle cell trait at 13.1 percent and dis
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Tropical Medicine
- Vol. 2026 (1) , 9151347
Association of Helicobacter pylori Coinfection With Tuberculosis Disease Severity and Treatment Outcomes
Background: Helicobacter pylori (HP) has immunomodulatory properties, but its relationship with tuberculosis (TB) severity and outcomes remains uncertain. We evaluated the association between HP infection and TB severity and explored factors associated with HP coinfection and TB treatment outcomes. Methods: We enrolled adults (≥ 18 years) with drug‐sensitive, newly diagnosed, bacteriologically confirmed pulmonary TB from two public clinics in Uganda. HP infection was determined using stool antigen testing. Severe TB was defined as GeneXpert cycle threshold < 16 or smear grade 3+ (microbiological), Bandim TBscore ≥ 8 (clinical), and chest X‐ray Timika score > 71 (radiological). Treatment outcomes were determined ≥ 7 months after treatment initiation. Results: Among 200 participants, 67 (33.5%) were HP positive. Severe radiological TB was more frequent among HP‐positive participants (34.8% vs. 22.1%, p = 0.060). Severe clinical (14.9% vs. 11.3%, p = 0.549) and microbiological TB (40.0% vs. 33.8%, p = 0.856) were also more frequent in HP. HP was not significantly associated with severe radiological (adjusted prevalence ratio [aPR] 1.56; 95% CI 0.96–2.53, p = 0.074), clinical (aPR 1.17; 95% CI 0.53–2.60, p = 0.694), or microbiological TB (aPR 1.14; 95% CI 0.80–1.63, p = 0.462). HP coinfection was independently associated with rural residence (aPR 1.61; 95% CI 1.04–2.47, p = 0.031), anorexia (aPR 1.72; 95% CI 1.01–2.90, p = 0.045), and lower diastolic blood pressure (aPR 0.98; 95% CI 0.96–1.00, p = 0.013). TB treatment success was similar among those with and without HP (95.5% vs. 95.5%, p = 0.180). Conclusion: HP was not significantly associated with TB severity or outcomes, though a trend toward greater radiological severity warrants further investigation in larger, prospective studies.
- 1 January 2026
- Published by Wiley in Journal of Tropical Medicine
- Vol. 2026 (1) , 9151347
Open AccessAssociation of Helicobacter pylori Coinfection With Tuberculosis Disease Severity and Treatment Outcomes
Background: Helicobacter pylori (HP) has immunomodulatory properties, but its relationship with tuberculosis (TB) severity and outcomes remains uncertain. We evaluated the association between HP infection and TB severity and explored factors associated with HP coinfection and TB treatment outcomes. Methods: We enrolled adults (≥ 18 years) with drug‐sensitive, newly diagnosed, bacteriologically confirmed pulmonary TB from two public clinics in Uganda. HP infection was determined using stool antigen testing. Severe TB was defined as GeneXpert cycle threshold < 16 or smear grade 3+ (microbiological), Bandim TBscore ≥ 8 (clinical), and chest X‐ray Timika score > 71 (radiological). Treatment outcomes were determined ≥ 7 months after treatment initiation. Results: Among 200 participants, 67 (33.5%) were HP positive. Severe radiological TB was more frequent among HP‐positive participants (34.8% vs. 22.1%, p = 0.060). Severe clinical (14.9% vs. 11.3%, p = 0.549) and microbiological TB (40.0% vs. 33.8%, p = 0.856) were also more frequent in HP. HP was not significantly associated with severe radiological (adjusted prevalence ratio [aPR] 1.56; 95% CI 0.96–2.53, p = 0.074), clinical (aPR 1.17; 95% CI 0.53–2.60, p = 0.694), or microbiological TB (aPR 1.14; 95% CI 0.80–1.63, p = 0.462). HP coinfection was independently associated with rural residence (aPR 1.61; 95% CI 1.04–2.47, p = 0.031), anorexia (aPR 1.72; 95% CI 1.01–2.90, p = 0.045), and lower diastolic blood pressure (aPR 0.98; 95% CI 0.96–1.00, p = 0.013). TB treatment success was similar among those with and without HP (95.5% vs. 95.5%, p = 0.180). Conclusion: HP was not significantly associated with TB severity or outcomes, though a trend toward greater radiological severity warrants further investigation in larger, prospective studies.
- Open Access
- 23 June 2025
- Published by Springer Nature in Research Square
The resurgence of blackwater fever among children in sub-Saharan Africa: A scoping Review
Background: Blackwater fever (BWF), a life-threatening complication of Plasmodium falciparum malaria, has re-emerged as a significant health concern among children in sub-Saharan Africa (SSA). Characterized by acute intravascular hemolysis, hemoglobinuria, and severe anemia, BWF necessitates urgent medical intervention. Despite its clinical severity, data on its burden, risk factors, and management remain fragmented. Therefore, this scoping review aimed to systematically map the existing literature on BWF in SSA, focusing on its epidemiology, clinical presentation, risk factors, management strategies, and outcomes among children in SSA. Methods: Following the Arksey and O’Malley framework, a comprehensive search was conducted across six databases (PubMed, Embase, Cochrane Library, CINAHL, PsycINFO, web of science) and grey literature sourcesincluding preprint servers, conference proceedings, theses, dissertations, WHO reports and clinical trials registries (PACTR, clinicaltrials.gov). Studies published from inception to December 2024 were included. Data were extracted and synthesized narratively, with findings categorized thematically by epidemiology, clinical features, risk factors, management, and outcomes. Results: BWF was geographical clustered in East and Central Africa, particularly Uganda (53.8%) and the DRC (26.9%). Prevalence ranged from 4.4% to 52.7%, with higher incidence during rainy seasons. MBL2 AA polymorphisms, elevated IgG1 and quinine exposure (aOR 50.19-57.33) were significant contributors while G6PD deficiency (G6PDd) had conflicting associations. Clinical hallmarks were dark urine (100% of cases), jaundice (22.7-100%), and severe anemia (23.7-77%) aligning with the “hemolytic triad” reported in BWF. Acute kidney injury (AKI) (16.2-90.6% of cases) and recurrent episodes (50-68% readmission rates) exacerbated morbidity. Diagnosis relied on clinical criteria, with limited laboratory confirmation, while management emphasized artemisinin-based therapies and supportive care. Delays in blood transfusions and renal replacement therapy contributed to poor outcomes. Conclusion: BWF resurgence in SSA highlights critical gaps in diagnostics, equitable care, and adherence to artemisinin-based treatments. Targeted surveillance during malaria peaks, standardized diagnostic protocols, and improved access to supportive therapies are urgently needed to mitigate BWF-associated mortality and morbidity in high-burden regions. Trial registration: OSF https://doi.org/10.17605/OSF.IO/QNPKV
- 23 June 2025
- Published by Springer Nature in Research Square
Open AccessThe resurgence of blackwater fever among children in sub-Saharan Africa: A scoping Review
Background: Blackwater fever (BWF), a life-threatening complication of Plasmodium falciparum malaria, has re-emerged as a significant health concern among children in sub-Saharan Africa (SSA). Characterized by acute intravascular hemolysis, hemoglobinuria, and severe anemia, BWF necessitates urgent medical intervention. Despite its clinical severity, data on its burden, risk factors, and management remain fragmented. Therefore, this scoping review aimed to systematically map the existing literature on BWF in SSA, focusing on its epidemiology, clinical presentation, risk factors, management strategies, and outcomes among children in SSA. Methods: Following the Arksey and O’Malley framework, a comprehensive search was conducted across six databases (PubMed, Embase, Cochrane Library, CINAHL, PsycINFO, web of science) and grey literature sourcesincluding preprint servers, conference proceedings, theses, dissertations, WHO reports and clinical trials registries (PACTR, clinicaltrials.gov). Studies published from inception to December 2024 were included. Data were extracted and synthesized narratively, with findings categorized thematically by epidemiology, clinical features, risk factors, management, and outcomes. Results: BWF was geographical clustered in East and Central Africa, particularly Uganda (53.8%) and the DRC (26.9%). Prevalence ranged from 4.4% to 52.7%, with higher incidence during rainy seasons. MBL2 AA polymorphisms, elevated IgG1 and quinine exposure (aOR 50.19-57.33) were significant contributors while G6PD deficiency (G6PDd) had conflicting associations. Clinical hallmarks were dark urine (100% of cases), jaundice (22.7-100%), and severe anemia (23.7-77%) aligning with the “hemolytic triad” reported in BWF. Acute kidney injury (AKI) (16.2-90.6% of cases) and recurrent episodes (50-68% readmission rates) exacerbated morbidity. Diagnosis relied on clinical criteria, with limited laboratory confirmation, while management emphasized artemisinin-based therapies and supportive care. Delays in blood transfusions and renal replacement therapy contributed to poor outcomes. Conclusion: BWF resurgence in SSA highlights critical gaps in diagnostics, equitable care, and adherence to artemisinin-based treatments. Targeted surveillance during malaria peaks, standardized diagnostic protocols, and improved access to supportive therapies are urgently needed to mitigate BWF-associated mortality and morbidity in high-burden regions. Trial registration: OSF https://doi.org/10.17605/OSF.IO/QNPKV
- Open Access
- 4 December 2024
- Published by Springer Nature in Research Square
Evaluating Instructor Feedback Practices in a Clinical Learning Environment in a Developing World Setting; a Qualitative Study.
Background Feedback is an essential component in medical education. Delivering timely and relevant feedback to individual students enhances workplace-based learning. There is increasing evidence that current feedback practices are not fit for purpose. However, there’s paucity of data on studies evaluating how feedback is given by tutors to students in developing countries. The study sought to evaluate the feedback practices of tutors of clinical medicine students in the facilitation of workplace learning. Methodology It was a qualitative study design. The study was conducted at Kampala International University in Tanzania, KIUT. The study participants were clinical medicine (14) tutors and (22) third year technician certificate in clinical medicine students. Data was collected through In-depth Interviews. The transcribed data was analyzed by inductive thematic analysis Results This study revealed five key themes: Feedback Delivery and Approach, Feedback Timing, Feedback Content, student Engagement and Participation, Challenges in giving feedback. Most tutors provided constructive, timely, and engaging feedback. The challenges dominantly were; Students not being receptive to feedback, Individual differences. Diverse learning styles, student resistance to act on feedback. Notably, most of the students were dissatisfied with the feedback provided citing its absence, delay, inconsistency, discouraging comments, and harsh language used by certain teachers. Conclusion Generally, the clinical tutors provided feedback that was constructive and student engaging but lacked the crucial aspect of observed performance and student reflection; hence an incomplete feedback process. Moreover, a majority of students expressed dissatisfaction with it. To improve impact of feedback on student learning and growth in clinical settings, institutions should implement Faculty Development Programmes that will provide training and support to tutors on effective feedback practices.
- 4 December 2024
- Published by Springer Nature in Research Square
Open AccessEvaluating Instructor Feedback Practices in a Clinical Learning Environment in a Developing World Setting; a Qualitative Study.
Background Feedback is an essential component in medical education. Delivering timely and relevant feedback to individual students enhances workplace-based learning. There is increasing evidence that current feedback practices are not fit for purpose. However, there’s paucity of data on studies evaluating how feedback is given by tutors to students in developing countries. The study sought to evaluate the feedback practices of tutors of clinical medicine students in the facilitation of workplace learning. Methodology It was a qualitative study design. The study was conducted at Kampala International University in Tanzania, KIUT. The study participants were clinical medicine (14) tutors and (22) third year technician certificate in clinical medicine students. Data was collected through In-depth Interviews. The transcribed data was analyzed by inductive thematic analysis Results This study revealed five key themes: Feedback Delivery and Approach, Feedback Timing, Feedback Content, student Engagement and Participation, Challenges in giving feedback. Most tutors provided constructive, timely, and engaging feedback. The challenges dominantly were; Students not being receptive to feedback, Individual differences. Diverse learning styles, student resistance to act on feedback. Notably, most of the students were dissatisfied with the feedback provided citing its absence, delay, inconsistency, discouraging comments, and harsh language used by certain teachers. Conclusion Generally, the clinical tutors provided feedback that was constructive and student engaging but lacked the crucial aspect of observed performance and student reflection; hence an incomplete feedback process. Moreover, a majority of students expressed dissatisfaction with it. To improve impact of feedback on student learning and growth in clinical settings, institutions should implement Faculty Development Programmes that will provide training and support to tutors on effective feedback practices.
- Open Access
- 29 July 2024
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 24 (1) , 1-8
The Ugandan sickle Pan-African research consortium registry: design, development, and lessons
Sub-Saharan Africa bears the highest burden of sickle cell disease (SCD) globally with Nigeria, Democratic Republic of Congo, Tanzania, Uganda being the most affected countries. Uganda reports approximately 20,000 SCD births annually, constituting 6.67% of reported global SCD births. Despite this, there is a paucity of comprehensive data on SCD from the African continent. SCD registries offer a promising avenue for conducting prospective studies, elucidating disease severity patterns, and evaluating the intricate interplay of social, environmental, and genetic factors. This paper describes the establishment of the Sickle Pan Africa Research Consortium (SPARCo) Uganda registry, encompassing its design, development, data collection, and key insights learned, aligning with collaborative efforts in Nigeria, Tanzania, and Ghana SPARCo registries. The registry was created using pre-existing case report forms harmonized from the SPARCo data dictionary and ontology to fit Uganda clinical needs. The case report forms were developed with SCD data elements of interest including demographics, consent, baseline, clinical, laboratory and others. That data was then parsed into a customized REDCap database, configured to suit the optimized ontologies and support retrieval aggregations and analyses. Patients were enrolled from one national referral and three regional referral hospitals in Uganda. A nationwide electronic patient-consented registry for SCD was established from four regional hospitals. A total of 5,655 patients were enrolled from Mulago National Referral Hospital (58%), Jinja Regional Referral (14.4%), Mbale Regional Referral (16.9%), and Lira Regional Referral (10.7%) hospitals between June 2022 and October 2023. Uganda has been able to develop a SCD registry consistent with data from Tanzania, Nigeria and Ghana. Our findings demonstrate that it’s feasible to develop longitudinal SCD registries in sub-Saharan Africa. These registries will be crucial for facilitating a range of studies, including the analysis of SCD clinical phenotypes and patient outcomes, newborn screening, and evaluation of hydroxyurea use, among others. This initiative underscores the potential for developing comprehensive disease registries in resource-limited settings, fostering collaborative, data-driven research efforts aimed at addressing the multifaceted challenges of SCD in Africa.
- 29 July 2024
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 24 (1) , 1-8
Open AccessThe Ugandan sickle Pan-African research consortium registry: design, development, and lessons
Sub-Saharan Africa bears the highest burden of sickle cell disease (SCD) globally with Nigeria, Democratic Republic of Congo, Tanzania, Uganda being the most affected countries. Uganda reports approximately 20,000 SCD births annually, constituting 6.67% of reported global SCD births. Despite this, there is a paucity of comprehensive data on SCD from the African continent. SCD registries offer a promising avenue for conducting prospective studies, elucidating disease severity patterns, and evaluating the intricate interplay of social, environmental, and genetic factors. This paper describes the establishment of the Sickle Pan Africa Research Consortium (SPARCo) Uganda registry, encompassing its design, development, data collection, and key insights learned, aligning with collaborative efforts in Nigeria, Tanzania, and Ghana SPARCo registries. The registry was created using pre-existing case report forms harmonized from the SPARCo data dictionary and ontology to fit Uganda clinical needs. The case report forms were developed with SCD data elements of interest including demographics, consent, baseline, clinical, laboratory and others. That data was then parsed into a customized REDCap database, configured to suit the optimized ontologies and support retrieval aggregations and analyses. Patients were enrolled from one national referral and three regional referral hospitals in Uganda. A nationwide electronic patient-consented registry for SCD was established from four regional hospitals. A total of 5,655 patients were enrolled from Mulago National Referral Hospital (58%), Jinja Regional Referral (14.4%), Mbale Regional Referral (16.9%), and Lira Regional Referral (10.7%) hospitals between June 2022 and October 2023. Uganda has been able to develop a SCD registry consistent with data from Tanzania, Nigeria and Ghana. Our findings demonstrate that it’s feasible to develop longitudinal SCD registries in sub-Saharan Africa. These registries will be crucial for facilitating a range of studies, including the analysis of SCD clinical phenotypes and patient outcomes, newborn screening, and evaluation of hydroxyurea use, among others. This initiative underscores the potential for developing comprehensive disease registries in resource-limited settings, fostering collaborative, data-driven research efforts aimed at addressing the multifaceted challenges of SCD in Africa.